Chemed (CHE) Cash from Financing Activities (2009 - 2026)

Chemed (CHE) has reported Cash from Financing Activities for 18 consecutive years, with -$108.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 359.21% year-over-year to -$108.1 million; the TTM figure through Mar 2026 stood at -$517.3 million (down 40.97% YoY), while the FY2025 annual figure was -$432.8 million, down 20.48% from the prior year.
• Cash from Financing Activities came in at -$108.1 million for Q1 2026 at Chemed, up from -$172.8 million in the prior quarter.
• The five-year high for Cash from Financing Activities was -$263000.0 in Q3 2023, with the low at -$212.5 million in Q4 2024.
• Average Cash from Financing Activities over 5 years is -$69.9 million, with a median of -$53.4 million recorded in 2022.
• Across the five-year window, Cash from Financing Activities soared 99.34% in 2023 and plunged 21365.02% in 2024, its largest moves.
• Year by year, Cash from Financing Activities stood at -$14.4 million in 2022, then surged by 57.64% to -$6.1 million in 2023, then sank by 3392.1% to -$212.5 million in 2024, then climbed by 18.67% to -$172.8 million in 2025, then jumped by 37.46% to -$108.1 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$108.1 million, -$172.8 million, and -$189.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.